Acute Lymphocytic Leukemia Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Completed
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
- Busulfan (BU)
- +2 more
- Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
2022-03-30
Mar 30, 2022M
Recruiting
- Acute Lymphocytic Leukemia
- Lymphoma
- Biological/Genetically Modified T cells
- Cyclophosphamide-based chemotherapy
- New York, New YorkMemorial Sloan Kettering Cancer Center
2022-04-07
Apr 7, 2022N
Completed
- Chronic Myelogenous Leukemia
- +9 more
- Fludarabine
- +3 more
- Atlanta, GeorgiaNorthside Hospital
2022-04-04
Apr 4, 2022I
Not yet recruiting
- Acute Lymphocytic Leukemia
- LCAR-AIO Cells
- Beijing, Beijing, China
- +1 more
2022-03-14
Mar 14, 2022W
Recruiting
- Acute Myelogenous Leukemia
- +4 more
- Stem cell transplantation
- +3 more
- Saint Louis, MissouriWashington University School of Medicine
2022-03-10
Mar 10, 2022N
Terminated
- Acute Myeloid Leukemia
- +3 more
- Fludarabine
- Total Marrow Irradiation (TMI)
- Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
2022-02-22
Feb 22, 2022W
Recruiting
- Non-hodgkin Lymphoma
- Acute Lymphocytic Leukemia
- Saint Louis, MissouriWashington University School of Medicine
2022-03-01
Mar 1, 2022U
Not yet recruiting
- Acute Lymphocytic Leukemia
- +3 more
- Washington, District of Columbia
- +2 more
2022-02-21
Feb 21, 2022N
Recruiting
- Non Hodgkin Lymphoma
- +8 more
- Chicago, Illinois
- +1 more
2022-02-14
Feb 14, 2022U
Recruiting
- Multiple Myeloma
- +11 more
- Pre-biotic foods/drinks
- Charlottesville, VirginiaUniversity of Virginia
2022-02-14
Feb 14, 2022B
Active, not recruiting
- B Cell Lymphoma
- +2 more
- CD19CAR-28-zeta T cells
- Ipilimumab
- Houston, Texas
- +1 more
2022-02-10
Feb 10, 2022I
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Ghent, Belgium
- +23 more
2022-02-07
Feb 7, 2022B
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
- Antithymocyte Globulin
- Clofarabine
- Boston, Massachusetts
- +1 more
2022-01-25
Jan 25, 2022B
Recruiting
- Non-Hodgkin Lymphoma
- +2 more
- CD19 CAR T Cells
- +2 more
- Houston, Texas
- +1 more
2022-01-11
Jan 11, 2022N
Not yet recruiting
- Acute Myeloid Leukemia
- +3 more
- Fludarabine + Total Marrow Irradiation
- Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
2022-01-07
Jan 7, 2022T
Completed
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Fairway, KansasUniversity of Kansas Cancer Center - Clinical Research Center
2022-01-12
Jan 12, 2022O
Not yet recruiting
- Acute Leukemia
- +6 more
- Cyclophosphamide
- +8 more
- (no location specified)
2021-12-08
Dec 8, 2021V
Active, not recruiting
- Hodgkin's Lymphoma
- +17 more
- mycophenolate mofetil
- +2 more
- Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
2021-12-21
Dec 21, 2021I
Recruiting
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- +3 more
- Gilbert, Arizona
- +14 more
2021-12-03
Dec 3, 2021M
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
- Birmingham, Alabama
- +38 more
2021-11-02
Nov 2, 2021W
Recruiting
- Acute Myelogenous Leukemia
- +9 more
- Winston-Salem, North CarolinaWake Forest Baptist Health
2021-11-23
Nov 23, 2021M
Active, not recruiting
- B-Lymphoid Malignancies
- +3 more
- Fludarabine
- +4 more
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2021-11-18
Nov 18, 2021N
Active, not recruiting
- Mucopolysaccharidosis I
- +15 more
- Human Placental Derived Stem Cell
- Denver, Colorado
- +2 more
2021-10-29
Oct 29, 2021M
Completed
- Acute Myelogenous Leukemia
- +4 more
- Single Umbilical Cord Blood Unit Transplant
- +6 more
- Birmingham, Alabama
- +37 more
2021-10-13
Oct 13, 2021A
Completed
- Relapsed or Refractory Haematological Malignancies Including
- +10 more
- Aachen, Germany
- +11 more
2021-10-21
Oct 21, 2021